secwatch.observer — SEC 8-K summary
======================================

Issuer:     Passage BIO, Inc. (PASG)
CIK:        0001787297
Form:       8-K
Filed at:   2026-03-10T23:59:59+00:00
Accession:  0001104659-26-025550
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Passage Bio terminates Hopewell lease; pays $4.8M fee, cash runway to Q1 2027
-----------------------------------------------------------------------------

- Terminated 62,000 sq ft lab lease (15-year term from March 2021) via Termination Agreement dated March 4, 2026.
- Company paid ~$4.8M termination fee plus accrued rent through February 14, 2026.
- All operations at Hopewell facility ceased after January 2025 restructuring.
- Company expects existing cash to fund operations through Q1 2027, but actual burn may differ.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787297/000110465926025550/0001104659-26-025550-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787297/000110465926025550/tm268398d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-025550

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer